Skip to main content
. 2017 Apr 7;8(24):38592–38601. doi: 10.18632/oncotarget.16951

Table 2. Univariate analysis for overall survival.

Variables Hazard ratio (95% CI) p-value
FGF19 0.48 (0.23–1.00) 0.047
FGF21 0.47 (0.22–0.99) 0.041
FGFR4 0.35 (0.17–0.74) 0.004
KLB 0.44 (0.20–0.94) 0.029
CYP8B1 0.43 (0.20–0.92) 0.024
ADH1B 0.47 (0.22–1.00) 0.045
CDKN1B 0.35 (0.16–0.74) 0.005
NCOR1 0.45 (0.22–0.96) 0.033
NF1 0.36 (0.17–0.76) 0.006
SUPV3L1 0.44 (0.21–0.92) 0.026
TIAL1 0.45 (0.21–0.96) 0.034
NROB2 0.28 (0.13–0.60) 0.001
MAP2K3 0.38 (0.18–0.81) 0.009
MYC 0.47 (0.22–0.98) 0.040
CYP2EA 0.25 (0.11–0.56) < 0.001
LG5R 0.45 (0.22–0.95) 0.031

Abbreviations: CI = confidence interval.